146 related articles for article (PubMed ID: 37473682)
1. Novel insights into STAT3 in renal diseases.
Yu JT; Fan S; Li XY; Hou R; Hu XW; Wang JN; Shan RR; Dong ZH; Xie MM; Dong YH; Shen XY; Jin J; Wen JG; Liu MM; Wang W; Meng XM
Biomed Pharmacother; 2023 Sep; 165():115166. PubMed ID: 37473682
[TBL] [Abstract][Full Text] [Related]
2. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
3. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
[TBL] [Abstract][Full Text] [Related]
4. T cell-specific STAT3 deficiency abrogates lupus nephritis.
Yoshida N; He F; Kyttaris VC
Lupus; 2019 Oct; 28(12):1468-1472. PubMed ID: 31551033
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into NOD-like receptors in renal diseases.
Jin J; Zhou TJ; Ren GL; Cai L; Meng XM
Acta Pharmacol Sin; 2022 Nov; 43(11):2789-2806. PubMed ID: 35365780
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
Edwards LJ; Mizui M; Kyttaris V
Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
[TBL] [Abstract][Full Text] [Related]
7. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.
Du Y; Kong C
Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258
[TBL] [Abstract][Full Text] [Related]
8. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.
Li S; Priceman SJ; Xin H; Zhang W; Deng J; Liu Y; Huang J; Zhu W; Chen M; Hu W; Deng X; Zhang J; Yu H; He G
PLoS One; 2013; 8(12):e81657. PubMed ID: 24324713
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
Lu S; Fan HW; Li K; Fan XD
Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
[TBL] [Abstract][Full Text] [Related]
10. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
Yang H; Xu A; Lv J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
[TBL] [Abstract][Full Text] [Related]
11. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
Chen Y; Chen L; Yang T
Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
[TBL] [Abstract][Full Text] [Related]
12. PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma.
Wei X; Yu L; Li Y
Biochem Biophys Res Commun; 2018 Jun; 500(3):650-657. PubMed ID: 29678569
[TBL] [Abstract][Full Text] [Related]
13. Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.
Yamamoto K; Hara T; Nakagawa T; Hirai M; Miyake H; Fujisawa M; Yano I
Target Oncol; 2018 Jun; 13(3):371-378. PubMed ID: 29633072
[TBL] [Abstract][Full Text] [Related]
14. Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.
Lv C; Huang Y; Liu ZX; Yu D; Bai ZM
Cancer Biomark; 2016 Jun; 17(1):41-7. PubMed ID: 27314291
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
16. GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism.
Shi Q; Xu R; Song G; Lu H; Xue D; He X; Xia Y
Cancer Gene Ther; 2020 Sep; 27(9):726-738. PubMed ID: 31636361
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a small molecule Natura-α and STAT3-SH2 domain to block Y705 phosphorylation and inhibit lupus nephritis.
Chiao JW; Melikian M; Han L; Xue C; Tsao A; Wang L; Mencher SK; Fallon J; Solangi K; Bertho G; Wang LG
Biochem Pharmacol; 2016 Jan; 99():123-31. PubMed ID: 26612419
[TBL] [Abstract][Full Text] [Related]
18. Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
Masuda A; Kamai T; Abe H; Arai K; Yoshida K
Biomed Res; 2009 Jun; 30(3):171-6. PubMed ID: 19574718
[TBL] [Abstract][Full Text] [Related]
19. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
20. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
